434 related articles for article (PubMed ID: 4015285)
1. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Ravid M; Lang R; Jutrin I
Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
Turner AS; Watson OF; Brocklehurst JE
Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
4. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
Wilcox RG; Hampton JR
Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
[TBL] [Abstract][Full Text] [Related]
6. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
[TBL] [Abstract][Full Text] [Related]
7. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
Comerford MB; Besterman EM
Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the duration of antihypertensive action of atenolol and metoprolol over a 24-hour period.
Crowe PF; Ferguson RJ
Curr Med Res Opin; 1985; 9(7):431-5. PubMed ID: 4028805
[TBL] [Abstract][Full Text] [Related]
10. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
Asplund J; Ohman P
Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
[TBL] [Abstract][Full Text] [Related]
11. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
BLoem TJ; Lindner PC
Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
[TBL] [Abstract][Full Text] [Related]
12. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil JJ; Louis WJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
[TBL] [Abstract][Full Text] [Related]
13. Experience with a slow-release formulation of oxprenolol.
Waal-Manning HJ; Spears GF
N Z Med J; 1978 Apr; 87(609):245-6. PubMed ID: 275650
[TBL] [Abstract][Full Text] [Related]
14. The effect of single-dose phenylpropanolamine on blood pressure in patients with hypertension controlled by beta blockers.
O'Connell MB; Gross CR
Pharmacotherapy; 1990; 10(2):85-91. PubMed ID: 2349137
[TBL] [Abstract][Full Text] [Related]
15. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
Frewin DB; Penhall RK; Leonello PP; Clapp RJ
N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
[No Abstract] [Full Text] [Related]
18. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
Klein G; Berger J; Olsson G; Menzel T
J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
[TBL] [Abstract][Full Text] [Related]
20. The effect of beta-blockers on mental performance on older hypertensive patients.
Gengo FM; Fagan SC; de Padova A; Miller JK; Kinkel PR
Arch Intern Med; 1988 Apr; 148(4):779-84. PubMed ID: 3281618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]